GemPharmatech (688046.SH) shareholder Qingdao National Pharmaceutical reduced its holdings by 888,200 shares, decreasing its stake to 5%.
Yaokang Biopharmaceuticals (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao Guoyao Daichuang...
GemPharmatech (688046.SH) announced on September 24, 2024, that its shareholder Qingdao Guoyao DaChuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has reduced its shareholding in the company by 888,200 shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, Qingdao Guoyao holds a reduced stake of 5% in the company.
Related Articles
CHINA JINMAO (00817) plans to increase its capital to Beijing Chao by 350 million yuan and to Beijing Manmao by 2.15 billion yuan.
Selected A-share Announcement | Brother Enterprises Holding(002562.SZ) expects a year-on-year increase in performance of 207%-253% for the first three quarters.
Changgao Electric Group (002452.SZ) plans to implement multiple rooftop photovoltaic projects with a total investment of 79.6177 million yuan.
CHINA JINMAO (00817) plans to increase its capital to Beijing Chao by 350 million yuan and to Beijing Manmao by 2.15 billion yuan.
Selected A-share Announcement | Brother Enterprises Holding(002562.SZ) expects a year-on-year increase in performance of 207%-253% for the first three quarters.
Changgao Electric Group (002452.SZ) plans to implement multiple rooftop photovoltaic projects with a total investment of 79.6177 million yuan.
